Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Authors
Keywords
-
Journal
Viruses-Basel
Volume 8, Issue 1, Pages 9
Publisher
MDPI AG
Online
2016-01-06
DOI
10.3390/v8010009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy
- (2015) J. J. Rojas et al. CLINICAL CANCER RESEARCH
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer-fighting viruses win approval
- (2015) Heidi Ledford NATURE
- Immune checkpoint modulation: Rational design of combination strategies
- (2015) Dmitriy Zamarin et al. PHARMACOLOGY & THERAPEUTICS
- The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells
- (2015) Lotte M.E. Berghauser Pont et al. PLoS One
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Oncolytic parvoviruses: from basic virology to clinical applications
- (2015) Antonio Marchini et al. Virology Journal
- Clinical Development of Immune Checkpoint Inhibitors
- (2015) Ayumu Ito et al. Biomed Research International
- Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
- (2015) L Vassilev et al. OncoImmunology
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
- (2014) James J. Cody et al. PLoS One
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Oncolytic Viruses and Their Application to Cancer Immunotherapy
- (2014) E. A. Chiocca et al. Cancer Immunology Research
- Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+T-cell response, prominent infiltration of CD8+lymphocytes and Th1 type polarization
- (2014) Tuuli Ranki et al. OncoImmunology
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
- (2014) Zong Sheng Guo et al. Frontiers in Oncology
- Pharmacological Modulation of Anti-Tumor Immunity Induced by Oncolytic Viruses
- (2014) Nicole E. Forbes et al. Frontiers in Oncology
- The histone deacetylase inhibitor valproic acid enhances equine herpesvirus type 1 (EHV-1)-mediated oncolysis of human glioma cells
- (2013) M C White et al. CANCER GENE THERAPY
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Synergistic combination of valproic acid and oncolytic parvovirus H-1PV as a potential therapy against cervical and pancreatic carcinomas
- (2013) Junwei Li et al. EMBO Molecular Medicine
- Myeloid-derived suppressor cells in cancer: recent progress and prospects
- (2013) Yazan S Khaled et al. IMMUNOLOGY AND CELL BIOLOGY
- Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma
- (2013) Antoni Ribas et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy
- (2013) Byram W Bridle et al. MOLECULAR THERAPY
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- New viruses for cancer therapy: meeting clinical needs
- (2013) Tanner S. Miest et al. NATURE REVIEWS MICROBIOLOGY
- Oncolytic virus therapy for cancer: the first wave of translational clinical trials
- (2013) Manish R. Patel et al. Translational Research
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Exploiting tumor epigenetics to improve oncolytic virotherapy
- (2013) Nicole E. Forbes et al. Frontiers in Genetics
- Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes
- (2013) Matteo Bellone et al. Frontiers in Oncology
- Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
- (2012) Sonia Tusell Wennier et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer
- (2012) Joan N Kyula et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
- (2012) K-W Peng et al. GENE THERAPY
- The Histone Deacetylase Inhibitor Valproic Acid Lessens NK Cell Action against Oncolytic Virus-Infected Glioblastoma Cells by Inhibition of STAT5/T-BET Signaling and Generation of Gamma Interferon
- (2012) Christopher A. Alvarez-Breckenridge et al. JOURNAL OF VIROLOGY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Molecular Mechanisms of Treg-Mediated T Cell Suppression
- (2012) Angelika Schmidt et al. Frontiers in Immunology
- Clinical development directions in oncolytic viral therapy
- (2011) R M Eager et al. CANCER GENE THERAPY
- Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells
- (2011) D R Kim et al. CANCER GENE THERAPY
- Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
- (2011) J D Dias et al. GENE THERAPY
- Strategies to Enhance Viral Penetration of Solid Tumors
- (2011) Elspeth Smith et al. HUMAN GENE THERAPY
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Equine Herpesvirus Type 1-Mediated Oncolysis of Human Glioblastoma Multiforme Cells
- (2011) M. J. Courchesne et al. JOURNAL OF VIROLOGY
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
- (2011) Alan Melcher et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies
- (2011) A. J. Christiansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic viruses and histone deacetylase inhibitors—A multi-pronged strategy to target tumor cells
- (2010) Thi Lien-Anh Nguyen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
- (2010) Howard L Kaufman et al. Future Oncology
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of Vaccinia Virus Based Oncolysis with Histone Deacetylase Inhibitors
- (2010) Heather MacTavish et al. PLoS One
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
- (2009) Christopher Alvarez-Breckenridge et al. CHEMICAL REVIEWS
- The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
- (2009) I. Lazar et al. JOURNAL OF VIROLOGY
- Intelligent Design: Combination Therapy With Oncolytic Viruses
- (2009) Kathryn Ottolino-Perry et al. MOLECULAR THERAPY
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
- (2008) Y Gao et al. CANCER GENE THERAPY
- The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells
- (2008) T Katsura et al. CANCER GENE THERAPY
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
- (2008) Paulo C. Rodríguez et al. IMMUNOLOGICAL REVIEWS
- Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
- (2008) Z. Xu et al. JOURNAL OF VIROLOGY
- Histone Deacetylase Inhibitors Augment Antitumor Efficacy of Herpes-based Oncolytic Viruses
- (2008) Akihiro Otsuki et al. MOLECULAR THERAPY
- Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
- (2008) Ta-Chiang Liu et al. MOLECULAR THERAPY
- Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
- (2008) Roberto Cattaneo et al. NATURE REVIEWS MICROBIOLOGY
- Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
- (2008) T. L.-A. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now